Quality of life in sarcopenia measured with the SarQoL questionnaire: A meta-analysis of individual patient data
Jazyk angličtina Země Irsko Médium print-electronic
Typ dokumentu časopisecké články, metaanalýza, systematický přehled
PubMed
38142467
DOI
10.1016/j.maturitas.2023.107902
PII: S0378-5122(23)00508-X
Knihovny.cz E-zdroje
- Klíčová slova
- Health-related quality of life, Individual-patient data meta-analysis, SarQoL, Sarcopenia,
- MeSH
- kvalita života * MeSH
- lidé MeSH
- prevalence MeSH
- průzkumy a dotazníky MeSH
- sarkopenie * epidemiologie MeSH
- senioři MeSH
- Check Tag
- lidé MeSH
- senioři MeSH
- Publikační typ
- časopisecké články MeSH
- metaanalýza MeSH
- systematický přehled MeSH
Age-related sarcopenia, resulting from a gradual loss in skeletal muscle mass and strength, is pivotal to the increased prevalence of functional limitation among the older adult community. The purpose of this meta-analysis of individual patient data is to investigate the difference in health-related quality of life between sarcopenic individuals and those without the condition using the Sarcopenia Quality of Life (SarQoL) questionnaire. A protocol was published on PROSPERO. Multiple databases and the grey literature were searched until March 2023 for studies reporting quality of life assessed with the SarQoL for patients with and without sarcopenia. Two researchers conducted the systematic review independently. A two-stage meta-analysis was performed. First, crude (mean difference) and adjusted (beta coefficient) effect sizes were calculated within each database; then, a random effect meta-analysis was applied to pool them. Heterogeneity was measured using the Q-test and I2 value. Subgroup analyses were performed to investigate the source of potential heterogeneity. The strength of evidence of this association was assessed using GRADE. From the 413 studies identified, 32 were eventually included, of which 10 were unpublished data studies. Sarcopenic participants displayed significantly reduced health-related quality of life compared with non-sarcopenic individuals (mean difference = -12.32; 95 % CI = [-15.27; -9.37]). The model revealed significant heterogeneity. Subgroup analyses revealed a substantial impact of regions, clinical settings, and diagnostic criteria on the difference in health-related quality of life between sarcopenic and non-sarcopenic individuals. The level of evidence was moderate. This meta-analysis of individual patient data suggested that sarcopenia is associated with lower health-related quality of life measured with SarQoL.
Bogomolets National Medical University Department of Internal Medicine Kyiv Ukraine
CUHK Jockey Club Institute of Ageing The Chinese University of Hong Kong New Territories Hong Kong
Department of Gerontology Federal University of São Carlos Brazil
Department of Health Sciences University of Jaén Jaén Spain
Department of Health Services Research University of Maastricht Maastricht the Netherlands
Department of Laboratory Medicine Faculty of Medicine University of Debrecen Hungary
Department of Medicine 4 LMU University Hospital LMU Munich Germany
Department of Physiotherapy School of Health Rehabilitation Sciences University of Patras Rio Greece
Faculty of Nursing and Podiatry University of Valencia Valencia Spain
INSERM UMR 1033 Université de Lyon 5 Place d'Arsonval 69437 Lyon France
School of Gerontology and Long Term Care College of Nursing Taipei Medical University Taiwan
Servicio de Geriatría Hospital Universitario Ramón y Cajal IRYCIS Madrid Spain
Citace poskytuje Crossref.org